IFN-γ enhances TH1 polarisation of monocyte-derived dendritic cells matured with clinical-grade cytokines using serum-free conditions

Anticancer Research

Volumn 28, Issue 3 A, 2008, Pages 1467-1476

  Hildenbrand, Bernd ^a,d   Lorenzen, Dirk ^b   Sauer, Barbara ^a   Hertkorn, Christian ^a   Freudenberg, Marina A ^c   Peters, J Hinrich ^b   Nesselhut, Thomas ^b   Unger, Clemens ^a   Azemar, Marc ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Institute for Tumour Therapy   (Germany)

^c MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^d TUMOR BIOLOGY CENTER   (Germany)

Author keywords

Dendritic cells; Interferon gamma; Maturation; TH1 polarisation

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; RECOMBINANT GAMMA INTERFERON; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TOLL LIKE RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; CELL CULTURE; CELL MATURATION; CELL VIABILITY; CULTURE MEDIUM; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; UPREGULATION;

CULTURE MEDIA, SERUM-FREE; CYTOKINES; DENDRITIC CELLS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MONOCYTES; TH1 CELLS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 45949101993     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Annual Rev of Immunol 9: 271-296, 1991.
2. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252,1998.
3. Sallusto F and Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumour necrosis factor alpha. J Exp Med 179: 1109-1118, 1994.
4. Zhou LJ and Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Nat Acad Sci USA 93: 2588-2592, 1996.
5. Engleman EG: Dendritic cell-based cancer immunotherapy. Sem Oncol 30: 23-29, 2003.
6. Gilboa E: DC-based cancer vaccines. J Clin Invest 117: 1195-1203, 2007.
7. Thomas-Kaskel AK, Waller CF, Schulze-Seemann W and Veelken H: Immunotherapy with dendritic cells for prostate cancer. Int J Cancer 121: 467-473, 2007.
8. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT and Storkus WJ: Therapy of murine tumours with tumour peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183: 87-97, 1996.
9. Albert ML, Jegathesan M and Darnell RB: Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nature Immunol 2: 1010-1017, 2001.
10. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C and Bhardwaj N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. I Exp Med 193: 233-238, 2001.
11. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S and Caux C: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188: 373-386, 1998.
12. Nishioka Y, Hirao M, Robbins PD, Lotze MT and Tahara H: Induction of systemic and therapeutic antitumour immunity using intratumoural injection of dendritic cells genetically modified to express interleukin 12. Cancer Res 59: 4035-4041, 1999.
13. Rouard H, Marquet I, Léon A, Maison P, Haioun C, Copie-Bergmen C, Plonquet A, Farcet JP and Delfau-Larue MH: IL-12 secreting dendritic cells are required for optimum activation of human secondary lymphoid tissue T cells. J Immunother 25: 324-333, 2002.
14. Xu S, Koski GK, Faries M, Bedrosian I, Mick R, Maeurer M, Cheever MA, Cohen PA and Czerniecki BJ: Rapid high efficiency sensitization of CD8+ T cells to tumour antigens by dendritic cells leads to enhanced functional avidity and direct tumour recognition through an IL-12-dependent mechanism. J Immunol 171: 2251-2261, 2003.
15. Vieira PL, de Jong EC, Wierenga EA, Kapsenberg ML and Kalinski P: Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 164: 4507-4512, 2000.
16. Zobywalski A, Javorovic M, Frankenberger B, Pohla H, Kremmer E, Bigalke I and Schendel DJ: Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70. J Transl Med 12: 5-18, 2007.
17. Mailliard RB, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens CM, Kapsenberg ML, Kirkwood JM, Storkus WJ and Kalinski P: α-Type-1 polarized dendritic cells: A novel immunization tool with optimized CTL-inducing activity. Cancer Res 64: 5934-5937, 2004.
18. Hildenbrand B, Sauer B, Kalis O, Stoll C, Freudenberg MA, Niedermann G, Giesler JM, Jüttner E, Peters JH, Häring B, Leo R, Unger C and Azemar M: Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon gamma and vaccinated with autologous PSA-peptide loaded dendritic cells - a pilot study. Prostate 67: 500-508, 2007.
19. Jonuleit H, Kühn U, Müller G, Steinbrink K, Paragnik L, Schmitt E, Knop J and Enk AH: Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27: 3135-3142, 1997.
20. Mackensen A, Galanos C and Engelhardt R: Modulating activity of interferon-gamma on endotoxin-induced cytokine production in cancer patients. Blood 78: 3254-3328, 1991.
21. Galanos C and Freudenberg MA: Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiol 187: 346-356, 1993.
22. Freudenberg MA, Kalis C, Chvatchko Y, Merlin T, Gumenscheimer M and Galanos C: Role of interferons in LPS hypersensitivity. J Endotox Res 9: 308-312, 2003.
23. Hildenbrand B, Azemar M, Sauer B, Neumann F, Zimmermann M, Unger C, Freudenberg MA and Galanos C: In vitro maturation of human monocyte-derived dendritic cells with highly purified LPS-preparations from Salmonella minnesota R-mutants under serum-free conditions. Death, Danger and Immunity: Institute Pasteur, Paris; March 8-9, Poster, 2007.
24. H1, TH2 and nonpolarized T cells. Nature Immunol 1: 311-316, 2000.
25. Kajino K, Nakamura I, Bamba H, Sawai T and Ogasawara K: Involvement of IL-10 in exhaustion of myeloid dendritic cells and rescue by CD40 stimulation. Immunol 120: 28-37, 2007.